KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Gross Margin (2016 - 2025)

Evolent Health (EVH) has 11 years of Gross Margin data on record, last reported at 20.81% in Q3 2025.

  • For Q3 2025, Gross Margin rose 782.0% year-over-year to 20.81%; the TTM value through Sep 2025 reached 18.42%, up 246.0%, while the annual FY2024 figure was 14.38%, 907.0% down from the prior year.
  • Gross Margin reached 20.81% in Q3 2025 per EVH's latest filing, down from 22.59% in the prior quarter.
  • Across five years, Gross Margin topped out at 33.77% in Q4 2021 and bottomed at 11.71% in Q4 2024.
  • Average Gross Margin over 5 years is 22.14%, with a median of 22.49% recorded in 2021.
  • Peak YoY movement for Gross Margin: tumbled -1205bps in 2022, then surged 782bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 33.77% in 2021, then plummeted by -36bps to 21.72% in 2022, then fell by -16bps to 18.28% in 2023, then tumbled by -36bps to 11.71% in 2024, then skyrocketed by 78bps to 20.81% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 20.81% in Q3 2025, 22.59% in Q2 2025, and 21.19% in Q1 2025.